Multiple Myeloma Clinical Trials
A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 20 clinical trials
Multiple Myeloma Turkish Prospective Patient Registry (THD-MM-Reg)
This is a non-interventional, national, multi center, prospective multiple myeloma registry in Turkey
- 0 views
- 25 Jun, 2025
A Study of an MMSET Inhibitor in Patients with Relapsed and Refractory Multiple Myeloma
prevent the dimethylation of H3K36 in adult patients with relapsed or refractory multiple myeloma (RRMM).
- 0 views
- 25 Jun, 2025
- 4 locations
Study of ABBV-383 Assessing Adverse Events and Clinical Activity With Subcutaneous (SC) Injection in Adult Participants With Relapsed or Refractory Multiple Myeloma
Multiple myeloma (MM) is a cancer of the blood's plasma cells. The cancer is typically found in the bones and bone marrow (the spongy tissue inside of the bones) and can cause bone pain, fractures
- 0 views
- 03 Jul, 2025
- 15 locations
ATRA and Carfilzomib in Plasma Cell Myeloma Patients (ATRA)
plasma cell myeloma also commonly referred as Multiple Myeloma (MM), in patients considered refractory to proteasome inhibitors (PIs). Multiple myeloma is an incurable clonal plasma cell disorder that comprises 10% of
- 0 views
- 25 Jun, 2025
Bortezomib-bendamustine-melphalan vs Melphalan for Multiple Myeloma
) in relapsed multiple myeloma given from 2011 to 2018 at Uppsala University Hospital. This approach will be retrospectively compared to high dose melphalan (HDM) in the same setting in the years prior
- 0 views
- 24 Jun, 2025
The Norwegian Immunotherapy in Multiple Myeloma Study (NIMMS)
The goal of this observational study is to study the effectiveness and complications of novel immunotherapies used in the treatment of multiple myeloma in routine care in Norway. The aim is to
- 0 views
- 25 Jun, 2025
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
This is a phase II study to evaluate the outpatient administration of Teclistamab or Talquetamab in Multiple Myeloma patients
- 0 views
- 03 Jul, 2025
- 16 locations
VitD3 Supplementation in Patients With Multiple Myeloma
The goal of this clinical trial is to evaluate post-transplant immune reconstitution and lymphocyte recovery as well as the 3-year progression-free survival of patients with multiple myeloma in
- 0 views
- 03 Jul, 2025
- 1 location
Study of Belantamab Mafodotin With Carfilzomib, Pomalidomide, and Dexamethasone in Relapsed Multiple Myeloma
multiple myeloma that has gotten worse and is not responding to standard drugs that are used for treating multiple myeloma, including chimeric antigen receptor T-cell therapy.Participation in this research
- 0 views
- 03 Jul, 2025
- 1 location
Minimal Residual Disease Guided Maintenance Therapy With Belantamab Mafodotin and Lenalidomide After Autologous Hematopoietic Cell Transplantation in Patients With Newly Diagnosed Multiple Myeloma
To increase the conversion rate from MRD-positive to MRD-negative CR in patients with newly diagnosed multiple myeloma (NDMM) receiving post-transplant maintenance therapy with belantamab
- 0 views
- 03 Jul, 2025
- 1 location
- 1
- 2